Abstract
Acromegaly (ACRO) is associated with elevated cardiovascular risk, although the prevalence of coronary artery disease (CAD) is unclear. Increased epicardial adipose tissue (EAT) and elevated cystatin C (Cys-C) levels are cardiovascular risk factors, also related to the progression of CAD in several populations. To measure the severity and extent of CAD in ACRO and to determine if either EAT or Cys-C reflect higher cardiovascular risk in ACRO than in healthy controls. Case-control study, of 35 ACRO (19 males, 17 with active disease) and 35 age-,gender- and body mass index (BMI)-matched healthy controls; mean age was 48.1±8.1 years and mean BMI was 27.6±4.8 kg/m2. Cys-C was measured by an immunoturbidimetric assay. The 10-year risk of developing a coronary event was calculated using the Framingham Risk Score (FRS). EAT index (volume indexed to body surface area), and severity and extent of CAD were measured using a 256-slice multidetector computed tomography scanner (iCT-256 Philips Healthcare, Amsterdam). CAD lesions, EAT index, and severity/extent of CAD were similar between ACRO and controls. Forty-four percent of ACRO had mild coronary lesions associated with greater EAT index (ß 0.022, p=0.036). Cys-C levels correlated with both EAT index (ρ=0.386, p=0.031) and FRS (ρ=0.477, p=0.004) in ACRO only, despite similar prevalence of traditional cardiovascular risk factors. In a multiple linear regression model, both Cys-C levels (ß 0.369, p=0.007) and EAT index (ß 0.29, p=0.025) predicted FRS (R2 0.613). In ACRO, both Cys-C and EAT index might be used as non-invasive predictors of cardiovascular risk.
Funding Information
  • Instituto de Salud Carlos III
  • Ministerio de Ciencia e Innovación (FIS PI 11-00001, PI 14-0194)
  • Federación Española de Enfermedades Raras
  • Fundación Salud 2000
  • Ministerio de Economía y Competitividad

This publication has 40 references indexed in Scilit: